TipRanks
Pharma Mar SA (DE:PMRA)
FRANKFURT:PMRA
Germany Market
PMRA
Pharma Mar SA
RESEARCH TOOLSreports

Pharma Mar SA (PMRA) Stock News & Sentiment

0 Followers
Pharma Mar Continues September Share Buyback on Madrid Exchange
Premium
Company Announcements
Pharma Mar Continues September Share Buyback on Madrid Exchange
9d ago
Pharma Mar Wins U.K. Approval for Zepzelca Combo in Small-Cell Lung Cancer
Premium
Company Announcements
Pharma Mar Wins U.K. Approval for Zepzelca Combo in Small-Cell Lung Cancer
16d ago
Pharma Mar Details August Share Buyback Transactions on Madrid Bourse
Premium
Company Announcements
Pharma Mar Details August Share Buyback Transactions on Madrid Bourse
1M ago
Pharma Mar Flags Planned Loss of Zepzelca Second-Line SCLC Indication
Premium
Company Announcements
Pharma Mar Flags Planned Loss of Zepzelca Second-Line SCLC Indication
2M ago
Pharma Mar Wins New Global Approvals for Zepzelca Lung Cancer Regimen
Premium
Company Announcements
Pharma Mar Wins New Global Approvals for Zepzelca Lung Cancer Regimen
2M ago
Pharma Mar Steps Up July Share Buybacks on Madrid Market
Premium
Company Announcements
Pharma Mar Steps Up July Share Buybacks on Madrid Market
2M ago
Pharma Mar Board Endorses 2026 Half-Year Financial Report
Premium
Company Announcements
Pharma Mar Board Endorses 2026 Half-Year Financial Report
2M ago
More DE:PMRA News >

PMRA News on the Web

Pharma Mar Wins U.K. Approval for Zepzelca Combo in Small-Cell Lung Cancer
TipRanks News
Bullish
Pharma Mar (BME:PHM) Could Be 37% Below Fair Value Following Weak Half Year Earnings
Simply Wall St
Bullish
Analyst Estimates: Here's What Brokers Think Of Pharma Mar, S.A. (BME:PHM) After Its Half-Yearly Report
Simply Wall St
Neutral
PharmaMar’s Partner Merck Seeks Priority Approval in Japan for Zepzelca as First-Line SCLC Maintenance
TipRanks News
Bullish
Pharma Mar price target lowered to EUR 100 from EUR 120 at Chardan
TipRanks News
Neutral
EU clears PharmaMar’s Zepzelca combo for first‑line maintenance in aggressive lung cancer
TipRanks News
Bullish
A Look At Pharma Mar (BME:PHM) Valuation As Dividend Proposal Puts Shareholder Returns In Focus
Simply Wall St
Neutral
3 European Growth Companies With Insider Ownership Expecting 31% Earnings Growth
Simply Wall St
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:PMRA’s Media Buzz Sentiment?
Currently, no data Available
What is DE:PMRA’s weekly average amount of articles?
In an average week, 1 articles about DE:PMRA are published.
    What is DE:PMRA’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AMGNAmgen
    GKOSGlaukos
    OVIDOvid Therapeutics
    ABTAbbott Laboratories
    IQVIQVIA Holdings
    Showing the stocks with the most bullish news sentiment over the past week